AptarGroup, Inc. 10-Q Summary: Quarter Ended June 30, 2006
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2006, for AptarGroup, Inc., a Delaware corporation. The company operates in the packaging components industry, developing and manufacturing consumer product dispensing systems. Operations are organized into three reporting segments: Beauty & Home, Pharma, and Closures. The financial statements are unaudited and reflect the adoption of SFAS 123(R) regarding share-based payment effective January 1, 2006.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2006 |
Three Months Ended June 30, 2005 |
Six Months Ended June 30, 2006 |
Six Months Ended June 30, 2005 |
|---|---|---|---|---|
| Net Sales | $398,625 | $356,112 | $774,093 | $700,111 |
| Operating Income | $43,770 | $41,129 | $76,169 | $75,478 |
| Net Income | $27,668 | $29,324 | $47,478 | $51,392 |
| Diluted EPS | $0.77 | $0.81 | $1.31 | $1.41 |
| Operating Margin | 11.0% | 11.5% | 9.8% | 10.8% |
| Net Cash from Operations | N/A | N/A | $77,396 | $72,904 |
| Cash and Equivalents | $121,897 | N/A | $121,897 | N/A |
| Total Debt (Short + Long Term) | $264,646 | N/A | $264,646 | N/A |
Note: Total Debt calculated as Notes Payable ($117,190) + Current Maturities ($5,132) + Long-Term Obligations ($142,324).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 12% for the quarter and 11% for the six-month period compared to the prior year. Growth was driven by acquisitions (approx. 7% of total increase), price increases to offset material costs, and volume growth in the Beauty & Home segment.
- Profitability Decline: Despite revenue growth, Net Income decreased 6% for the quarter and 8% for the six-month period. This was primarily due to the adoption of SFAS 123(R), which resulted in approximately $9.2 million in stock option expense for the first half of 2006, and a higher effective tax rate (31.6% vs. 28.0% in the prior year) due to the absence of one-time tax benefits received in 2005.
- Cost Pressures: Cost of sales as a percentage of net sales increased slightly due to rising raw material costs (plastic resin and metals) and higher compliance costs in the Pharma segment.
- Acquisitions: The company acquired CCL Dispensing Systems, LLC for approximately $21.3 million in cash in Q1 2006, contributing to sales and operating income in the Closures segment.
Guidance, Outlook, and Risks
- Outlook: Management expects sales to continue increasing in the third quarter. Diluted EPS for Q3 2006 is projected to be in the range of $0.74 to $0.79, including a negative impact of approximately $0.04 per share from stock option expenses.
- Dividend Increase: On July 19, 2006, the Board declared a quarterly dividend increase from $0.20 to $0.22 per share.
- Capital Structure: On July 31, 2006, the company amended its revolving credit facility, increasing capacity to $200 million, and issued $50 million in 6.04% Senior Notes to refinance existing borrowings.
- Risks: Key risks include rising raw material costs (particularly metal and resin), the ability to pass these costs to customers, foreign currency exchange fluctuations (primary exposure to the Euro), and integration of recent acquisitions.
- Unusual Items: A workforce redeployment program in France is ongoing, with total expected costs of $7-$9 million over three years. Charges of $1.4 million (pre-tax) were recorded in the first half of 2006.
Investor Verification Checklist
- Stock Option Expense Impact: Verify the full-year impact of SFAS 123(R) adoption on operating margins and EPS, estimated at $13.3 million reduction in operating income for 2006.
- Raw Material Hedging: Assess the company's ability to pass through rising resin and metal costs to customers without losing market share.
- Debt Covenants: Confirm compliance with the new credit facility covenants (Interest coverage ratio of 3.5:1; Debt to total capital ratio max 55%). Current levels are well within limits (18:1 and 23% respectively).
- Acquisition Integration: Monitor the performance contribution of the CCL Dispensing acquisition to the Closures segment.
- Foreign Currency Exposure: Review the effectiveness of hedging strategies given the significant portion of operations (61%) located in Europe.